Across Health acquires a majority stake in Signature Pharma

Across Health announced today the acquisition of a majority stake in Signature Pharma, a leading digital consultancy for life sciences in Spain, which is managing innovative digital marketing and social media programs for Sanofi, Bayer, Esteve, Almirall, Angelini Farmacéutica and other leading pharmaceutical companies.

By adding the important Spanish market to its rapidly expanding global footprint (including most European markets, US and China), this move further strengthens the leadership position of Across Health in the digital marketing space in healthcare. With a compound annual growth rate of over 35% since its start in 2008, Across Health now supports close to 20 innovative pharma companies around the world; more than 60 expert consultants help these companies move to the "New Normal".

Fonny Schenk, CEO, Across Health, commented: "This is a great day for Across Health and Signature Pharma...Across Health is committed to offering its customers a unique palette of pragmatic, proven international and local consulting services for best-practice cross-channel strategy, execution and analytics. Thanks to this, we will hit the ground running in a key market in Europe. Across Health will continue to broaden and deepen its global footprint selectively, to further strengthen our unique position in this fast-growing market."

Beverly Smet, VP Europe South, Across Health commented: "I am extremely delighted that Signature Pharma is joining Across Health, which will kickstart our operations in the important Spanish market. Our dedicated network of affiliates allows us to seamlessly translate global programmes into coordinated local execution, while offering best-practice strategy & impact measurement services. I look forward to working with Eva and her team to make this into a big success!"

"We are excited to be joining the Across Health family. Through shared strategy, planning and account resources provided by Across Health, Signature Pharma will be able to better fulfill the increasingly sophisticated needs of the pharmaceutical industry in the digital area," said Eva Velasco, Managing Director, Signature Pharma. "The global infrastructure, expertise and experience available to us now will significantly enhance our capabilities while ensuring that we continue to offer world-class service, support and quality."